195 related articles for article (PubMed ID: 34500740)
1. Conjugated β-Cyclodextrin Enhances the Affinity of Folic Acid towards FRα: Molecular Dynamics Study.
Al-Thiabat MG; Gazzali AM; Mohtar N; Murugaiyah V; Kamarulzaman EE; Yap BK; Rahman NA; Othman R; Wahab HA
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500740
[TBL] [Abstract][Full Text] [Related]
2. Heterocyclic Substitutions Greatly Improve Affinity and Stability of Folic Acid towards FRα. an In Silico Insight.
Al-Thiabat MG; Saqallah FG; Gazzali AM; Mohtar N; Yap BK; Choong YS; Wahab HA
Molecules; 2021 Feb; 26(4):. PubMed ID: 33670773
[TBL] [Abstract][Full Text] [Related]
3. Interaction mechanism of novel fluorescent antifolates targeted with folate receptors α and β via molecular docking and molecular dynamic simulations.
Wang C; Zhang M; Shi S; Jiang Y; Fei X; Liu L; Ye D; Zhang S
J Mol Model; 2022 Jul; 28(8):205. PubMed ID: 35780236
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional insights on folate receptor α (FRα) by homology modeling, ligand docking and molecular dynamics.
Della-Longa S; Arcovito A
J Mol Graph Model; 2013 Jul; 44():197-207. PubMed ID: 23880302
[TBL] [Abstract][Full Text] [Related]
5. Type and size effect of functional groups on the novel antifolate target recognition folate receptors α and β: Docking, molecular dynamics and MM/PBSA study.
Jiang Y; Wang C; Zhang M; Fei X; Gu Y
J Mol Graph Model; 2020 Nov; 100():107663. PubMed ID: 32659629
[TBL] [Abstract][Full Text] [Related]
6. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
[TBL] [Abstract][Full Text] [Related]
7. Study of folate-based carbon nanotube drug delivery systems targeted to folate receptor α by molecular dynamic simulations.
Jiang Y; Wang C; Zhang M; Liu L; Gao X; Zhang S; Ye D
Int J Biol Macromol; 2023 Jul; 244():125386. PubMed ID: 37327924
[TBL] [Abstract][Full Text] [Related]
8. Interaction of compounds derived from the Chinese medicinal formula Huangqi Guizhi Wuwu Tang with stroke-related numbness and weakness targets: An in-silico docking and molecular dynamics study.
Lee S; Wong AR; Yang AWH; Hung A
Comput Biol Med; 2022 Jul; 146():105568. PubMed ID: 35508083
[TBL] [Abstract][Full Text] [Related]
9. Novel fluorescent antifolates that target folate receptors α and β: Molecular dynamics and density functional theory study.
Wang C; Jiang Y; Zhang M; Fei X; Gu Y
J Mol Graph Model; 2018 Oct; 85():40-47. PubMed ID: 30055477
[TBL] [Abstract][Full Text] [Related]
10. Intermediate states in the binding process of folic acid to folate receptor α: insights by molecular dynamics and metadynamics.
Della-Longa S; Arcovito A
J Comput Aided Mol Des; 2015 Jan; 29(1):23-35. PubMed ID: 25323390
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for molecular recognition of folic acid by folate receptors.
Chen C; Ke J; Zhou XE; Yi W; Brunzelle JS; Li J; Yong EL; Xu HE; Melcher K
Nature; 2013 Aug; 500(7463):486-9. PubMed ID: 23851396
[TBL] [Abstract][Full Text] [Related]
12. Folic Acid-Functionalized Nanomedicine: Folic Acid Conjugated Copolymer and Folate Receptor Interactions Disrupt Receptor Functionality Resulting in Dual Therapeutic Anti-Cancer Potential in Breast and Prostate Cancer.
DeCarlo A; Malardier-Jugroot C; Szewczuk MR
Bioconjug Chem; 2021 Mar; 32(3):512-522. PubMed ID: 33556240
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the value of competition assays in folate receptor-mediated drug delivery.
Jones SK; Sarkar A; Feldmann DP; Hoffmann P; Merkel OM
Biomaterials; 2017 Sep; 138():35-45. PubMed ID: 28551461
[TBL] [Abstract][Full Text] [Related]
14. In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: folate conjugated noscapine (Targetin).
Naik PK; Lopus M; Aneja R; Vangapandu SN; Joshi HC
J Comput Aided Mol Des; 2012 Feb; 26(2):233-47. PubMed ID: 22170255
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulation studies of novel β-lactamase inhibitor.
Ul Haq F; Abro A; Raza S; Liedl KR; Azam SS
J Mol Graph Model; 2017 Jun; 74():143-152. PubMed ID: 28432959
[TBL] [Abstract][Full Text] [Related]
16. Folate Receptor α-Modified Nanoparticles for Targeting of the Central Nervous System.
Kuplennik N; Lang K; Steinfeld R; Sosnik A
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39633-39647. PubMed ID: 31532618
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13.
Cruz JN; Costa JFS; Khayat AS; Kuca K; Barros CAL; Neto AMJC
J Biomol Struct Dyn; 2019 Apr; 37(6):1616-1627. PubMed ID: 29633908
[TBL] [Abstract][Full Text] [Related]
18. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
Shen Z; Li Y; Kohama K; Oneill B; Bi J
Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
[TBL] [Abstract][Full Text] [Related]
19. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
Thillainayagam M; Malathi K; Ramaiah S
J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266
[TBL] [Abstract][Full Text] [Related]
20. Initial Stages of Spontaneous Binding of Folate-Based Vectors to Folate Receptor-α Observed by Unbiased Molecular Dynamics.
Schaber EN; Ivanova N; Iliev S; Petrova J; Gocheva G; Madjarova G; Ivanova A
J Phys Chem B; 2021 Jul; 125(28):7598-7612. PubMed ID: 34247488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
